Literature DB >> 3213969

Morphometric and statistical analyses describing the in utero growth of human epidermis.

C A Foster1, J F Bertram, K A Holbrook.   

Abstract

Epidermal development of human embryonic and fetal skin from the lower limb was studied using morphometric and statistical methods. Epidermal growth, as defined by an increase in epidermal thickness and the number of cell layers, occurred in three distinct stages during the first and second trimesters. The first growth spurt occurred between 5 and 13 weeks estimated gestational age (EGA) and was followed by a plateau phase with little change in epidermal thickness from 14 to 21 weeks, after which the epidermis began to increase in height again. The periderm reached its maximal height by approximately 13 weeks EGA, and by 25 weeks was shed into the amniotic fluid. Thus, within a five-month period (5 to 25 weeks EGA) the epidermis changed from a single cell layer less than 10 micron thick to a 10 to 12-cell layer, keratinized epithelium greater than 60 micron thick. In contrast, epidermis from adult lower limb consisted of about 25 cell layers and was almost 75 micron in thickness. The age-related differences in epidermal thickness probably reflect changes in cell size and shape more than changes in the directional movement (apically vs. laterally) of proliferating keratinocytes, because the addition of cell layers throughout development was relatively constant. During the plateau phase, when there is a rapid increase in fetal growth rate, the suprabasal keratinocytes become more flattened, thereby allowing for the addition of new cell layers while maintaining a relatively constant epidermal thickness.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3213969     DOI: 10.1002/ar.1092220213

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  1 in total

1.  Prenatal human skin expresses the antimicrobial peptide RNase 7.

Authors:  Christopher Schuster; Regine Gläser; Christian Fiala; Wolfgang Eppel; Jürgen Harder; Jens-M Schröder; Adelheid Elbe-Bürger
Journal:  Arch Dermatol Res       Date:  2013-04-02       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.